Patent · US Active

Anti-IL-23 antibodies

US7872102B2 · kind B2 · utility

22Cited by

2References

3Claims

0Family size

Assignee

ELI LILLY AND COMPANY · US

Inventors

Catherine Brautigam Beidler · Poway, US
Stuart Willis Bright · Carmel, US
Craig Duane Dickinson · San Diego, US
Kristine Kay Kikly · Fortville, US
David Matthew Marquis · Encinitas, US
Alain P. Vasserot · South San Francisco, US

Key dates

Filing date	Aug 23, 2006
Grant date	Jan 18, 2011
Priority date	—
Expiry date	Jul 13, 2027

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07K2317/92
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention encompasses isolated antibodies, or antigen-binding portions thereof, that specifically bind to the p19 subunit of IL-23. These antibodies, or antigen-binding portions thereof, are high affinity, neutralizing antibodies useful for the treatment of autoimmune disease.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.